# Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure

> **NCT00151775** · PHASE2,PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 362 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** olmesartan medoxomil
- **DRUG:** placebo
- **DRUG:** olmesartan medoxomil

## Key facts

- **NCT ID:** NCT00151775
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2016-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151775, "Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00151775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*